Original Paper
Authors
Brenda P. Longas Vélez
Keywords
ozonoterapia
fibromialgia
dolor
Abstract
Fibromyalgia is a disease of unknown cause whose main symptom is widespread chronic skeletal muscle pain, accompanied by symptoms that alter the daily activities of patients. In this study we evaluated the impact of ozone therapy on improving patients’ pain and their daily activities to give them a better quality of life. The clinical experience is described by applying ozone therapy to 30 women between the ages of 30-65 years with diagnosis of Fibromyalgia, Visual Analog Scale (EVA) of 6-9, with a time of evolution of the disease between 1-10 years. Patients were treated with intramuscular O2-O3 with 10 sessions 2 times a week at doses of 15 μg / mL, together they were administered systemically 10 sessions 2 times a week alternating by rectal insufflation and intravenous application of saline solution 0.9% ozonated. The evolution of the patients was continued by monitoring the clinical symptoms and the evaluation of the Visual Analogue Scale.
The results showed an improvement of the pain with VAS in 33% of 3-4 in the second week, they improved the sleep disorder in 46.6%, the mood and in their daily activities in 40% and it appreciated A decrease in the amount of drugs they consumed in 30% of patients.
Ozone therapy can be considered as an interesting treatment as a coadjuvant in the symptomatology of fibromyalgia.
Ozone therapy, a supplement for patients with fibromyalgia
Keywords
ozone therapy
fibromyalgia
pain
Abstract
Fibromyalgia is a disease of unknown cause whose main symptom is chronic widespread musculoskeletal pain accompanied by symptoms that disrupt daily activities of patients. In this study the impact of ozone therapy in improving patients’ pain and daily activities to give them a better quality of life was assessed. Clinical experience is described using ozone therapy in 30 women aged 30-65 years diagnosed with Fibromyalgia, Visual Analogue Scale (VAS) 6-9, with a time of disease progression between 1-10 years. Patients were treated with O2-O3 intramuscular with 10 sessions 2 times a week at doses of 15 mg / mL, together were administered systemically 10 sessions 2 times a week alternating rectal insufflation and intravenous administration of saline 0.9% ozonated. The outcome of patients was continued by monitoring clinical symptoms and evaluation of the Visual Analogue Scale. The results showed an improvement in pain with 33% VAS 3-4 in the second week, improved sleep disorder in 46.6%, mood and daily activities by 40% and appreciated a decrease in the amount of drugs consumed by 30% of patients. The ozone therapy can be considered as an interesting as adjuvant therapy in the symptoms of fibromyalgia.
This post is also available in: 
Español (Spanish)
